文献速递慢阻肺呼吸道感染

缺氧诱导因子与慢性阻塞性肺疾病中的细菌感染

Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease.
PubMed 文献 · Respirology · 2019-10-30

本文综述了局部组织缺氧诱导的炎症、缺氧诱导因子(HIF)-1α及血小板活化因子受体(PAFR)在促进慢阻肺细菌感染中的作用。HIF-1α在慢阻肺患者肺内过表达,可上调气道上皮表面PAFR,而PAFR依赖性细菌(肺炎链球菌、流感嗜血杆菌和铜绿假单胞菌)利用该受体引发呼吸道和胃肠道感染。阻断PAFR可能为慢阻肺细菌感染提供新的抗菌策略。

要点

  • HIF-1α在慢阻肺患者肺内过表达,可上调气道上皮PAFR。
  • PAFR依赖性细菌利用PAFR引发呼吸道和胃肠道感染。
  • 阻断PAFR可能成为慢阻肺细菌感染的新型非抗生素抗菌策略。

核心结论

  • HIF-1α通过上调PAFR促进PAFR依赖性细菌感染,阻断PAFR可能为慢阻肺细菌感染提供新型抗菌方法。

研究设计与样本

  • 本文为综述,汇总局部组织缺氧诱导的炎症、HIF-1α和PAFR在慢阻肺细菌感染中作用的证据。

主要发现

  • HIF-1α是细胞对缺氧、氧化剂和炎症反应的重要转录调节因子,在慢阻肺患者肺内过表达。
  • HIF-1α表达增加可上调气道上皮表面PAFR,吸烟者及尤其慢阻肺患者中PAFR增加。
  • PAFR依赖性细菌包括肺炎链球菌、流感嗜血杆菌和铜绿假单胞菌,可引发呼吸道和胃肠道感染。
  • HIF-1α增强慢阻肺中PAFR依赖性细菌感染的重要性和机制尚不清楚。

临床怎么用

  • 阻断PAFR可能作为慢阻肺细菌感染的新型非抗生素抗菌策略。

局限性

  • HIF-1α增强慢阻肺中PAFR依赖性细菌感染的重要性和机制尚不清楚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COPD is a seriously disabling respiratory condition that inexorably progresses to disability and mortality. It affects approximately 10% of the population globally with a greater prevalence at advanced ages. Airway bacterial infections complicate the disease course in most COPD patients, leading to increased symptoms, more rapid decline in lung function, acute exacerbations and reduced quality of life. With increasing bacterial resistance to antibiotics and adverse effects of conventional treatments, new effective non-antibiotic antimicrobial therapies are urgently needed to manage COPD. Hypoxia-inducible factor (HIF)-1α is an important transcriptional regulator of cellular responses to hypoxia, oxidants and inflammation, and is overexpressed in the lungs of COPD patients. Recent evidence shows that increased HIF-1α expression can upregulate the platelet-activating factor receptor (PAFR) on the airway epithelial surface that is increased in smokers and particularly COPD patients. The receptor is utilized by PAFR-dependent bacteria (Streptococcus pneumoniae, Haemophilus influenzae and Pseudomonas aeruginosa) to induce infection in both the respiratory and gastrointestinal (GI) tracts. However, the importance and mechanism of HIF-1α in augmenting PAFR-dependent bacterial infections in COPD are poorly understood. Here, we review the evidence for the roles of local tissue hypoxia-induced inflammation, HIF-1α and PAFR in facilitating bacterial infections in COPD. Blocking PAFR may provide a novel antimicrobial approach to manage bacterial infections in COPD.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Shukla SD, Walters EH, Simpson JL, et al. Hypoxia-inducible factor and bacterial infections in chronic obstructive pulmonary disease. Respirology. 2019. PMID: 31663668. doi:10.1111/resp.13722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。